Prospective Study
Copyright ©The Author(s) 2021.
World J Gastrointest Oncol. Dec 15, 2021; 13(12): 2190-2202
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2190
Table 2 Clinical characteristics of anatomic resection and non-anatomic resection
Clinical characteristics
AR (n = 103)
NAR (n = 114)
P value
Age, yr (mean ± SD)54.1 ± 12.551.3 ± 12.20.095
Sex, n (%)0.812
Male93 (90.3)104 (91.2)
Female10 (9.7)10 (8.8)
ALT (U/mL)30.5 ± 14.529.8 ± 14.20.721
AST (U/mL)36.3 ± 28.940.6 ± 34.60.332
TBiL (μmol/L)17.0 ± 10.515.9 ± 9.00.098
Child-Pugh score, n (%)0.154
A103 (100)106 (93.0)
B0 (0)2 (7.0)
HBsAg, n (%)0.622
Positive88 (85.4)100 (87.7)
Negative15 (14.6)14 (12.3)
Liver cirrhosis, n (%)0.841
No21 (20.4)22 (19.3)
Yes82 (79.6)92 (80.7)
AFP (ng/mL), n (%)0.446
< 40071 (68.9)73 (64.0)
≥ 40032 (31.1)41 (36.0)
ICG-R15 (%)5.9 ± 3.55.4 ± 3.10.578
BCLC stage, n (%)0.867
0 + A46 (44.7)46 (40.4)
B + C57 (55.3)68 (59.6)
Operation method, n (%)0.423
Open24 (23.3)32 (28.1)
Laparoscopic79 (76.7)82 (71.9)
Operation time (min)171.4 ± 48.2165.5 ± 45.30.335
Blood loss (mL)210 ± 233170 ± 1750.233
Blood transfusion, n (%)0.774
No89 (86.4)100 (87.7)
Yes14 (13.6)14 (12.3)
Hepatic vascular occlusion, n (%)0.314
No27 (26.2)37 (32.5)
Yes76 (73.8)77 (67.5)
Largest tumor size, (cm)5.1 ± 3.64.7 ± 3.30.507
No. of tumors, n (%)0.884
Single75 (72.8)82 (71.9)
Multiple28 (27.2)32 (28.1)
Tumor encapsulation, n (%)0.051
No57 (55.3)66 (57.9)
Yes46 (44.7)48 (42.1)
Satellite lesion, n (%)0.822
Yes9 (8.7)9 (7.9)
No94 (91.3)105 (92.1)
Tumor differentiation stage, n (%)0.943
Edmondson I II51 (49.5)57 (50.0)
Edmondson III IV52 (50.5)57 (50.0)
Microvascular invasion, n (%)0.845
Yes37 (35.9)38 (33.3)
No66 (64.1)76 (66.7)